Stay updated on rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial

Sign up to get notified when there's something new on the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:25:54.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the safety or efficacy evaluation of rFVIIIFc (BIIB031) in previously untreated participants with severe hemophilia A.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:31.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying the need for a legally authorized representative to understand the study's purpose and risks, and provide informed consent. It also outlines key inclusion and exclusion criteria such as health conditions and prior treatments.
    Difference
    15%
    Check dated 2024-05-22T21:12:14.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:53:18.000Z thumbnail image

Stay in the know with updates to rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial

Enter your email address, and we'll notify you when there's something new on the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page.